(Q43485744)

23 November 2017

title

Serum erythropoietin concentrations in patients with myelodysplastic syndromes (English)

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

12 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

12 December 2022

author name string

C. Aul

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861540

12 December 2022

M. Arning

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861540

12 December 2022

V. Runde

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861540

12 December 2022

W. Schneider

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861540

12 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1861540

12 December 2022

publication date

1 January 1991

1 reference

full work available at URL

23 November 2017

https://api.elsevier.com/content/article/PII:014521269190025O?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

https://api.elsevier.com/content/article/PII:014521269190025O?httpAccept=text/plain

12 December 2022

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

12 December 2022

1 reference

23 November 2017

volume

15

1 reference

23 November 2017

issue

7

1 reference

23 November 2017

page(s)

571-575

1 reference

Classification of the myelodysplastic syndromes

23 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Proposals for the classification of the myelodysplastic syndromes

12 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis

12 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Decreased erythropoietin response in patients with the anemia of cancer

12 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

A radioimmunoassay for erythropoietin: serum levels in normal human subjects and patients with hemopoietic disorders

12 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates.

12 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Circulating erythropoietin in patients with myelodysplastic syndromes

12 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Erythropoietin response to anaemia in children with sickle cell disease and Fanconi's hypoproliferative anaemia

12 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification

12 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes

12 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome

12 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Two types of acquired idiopathic sideroblastic anaemia (AISA)

12 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Some aspects of erythrokinetics

12 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

12 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0145-2126(91)90025-O

12 December 2022

Identifiers

1 reference

23 November 2017

1 reference